Prevalence of Glaucoma in the Israeli Arab Population | NCT01546740

Studies
Prevalence of Glaucoma in the Israeli Arab Population

NCT01546740

Sponsor

Ziv Hospital

Status

Unknown status

Last Update Posted

Mar 7, 2012Estimated

Enrollment

15,000Estimated

Phase

Not provided

Conditions

Glaucoma

Interventions

Not provided

Countries

Israel

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Mar 2012

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jan 2012

Primary Completion Date

Apr 2012Estimated

Completion Date

May 2012Estimated

First Submitted Date

Mar 1, 2012

First Submission Date that Met QC Criteria

Mar 6, 2012

First Posted Date

Mar 7, 2012Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Mar 6, 2012

Last Update Posted Date

Mar 7, 2012Estimated

Oversight Module

Has Data Monitoring Committee (DMC)

Yes

Is FDA Regulated Drug

Not provided

Is FDA Regulated Device

Not provided

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

there is a variety of glaucoma prevalence within different populations. this study examine the prevalence of glaucoma in the Arab population in Israel' as well as the demographic variables and the compliance to treatment in the population.

Detailed Description

from Medical records of primary care clinic in the city of Tira. the patients are recruited, all glaucoma patients are above age of 20 years. they must suffer from CDR >= 0.5 with/without asymmetry with the other eye. or they suffer from glaucomatous damage to the visual fields.

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

15,000Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Glaucoma patients		all the ,medical records of patients who were diagnosed with primary open angle glaucoma, closed angle , pseudoexfoliative and neovascular glaucoma.

Interventions

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Cup-to-disk ratio (CDR) > 0.5 with asymmetry between the eyes
Intraocular pressure (IOP) > 23 mm Hg
Damage to the field of vision
Age- above 20 Yrs. old

Exclusion Criteria:

None

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

20 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

primary care clinics from 1 Arab city in the center of Israel

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Joseph Pikkel, M.D	Contact	+972508434206		pikel.y@ziv.health.gov.il
Otzem Chassid, M.D	Contact	+972506266059		otzem.c@ziv.health.gov.il

Overall Officials

Name	Affiliation	Role
Joseph Pikkel, M.D	Ziv Medical Center	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Ziv Medical Center	Recruiting	Safed		13120	Israel

Condition Browse Module

MeSH Terms

ID	Term
D005901	Glaucoma
D010349	Patient Compliance

Ancestor Terms

ID	Term
D009798	Ocular Hypertension
D005128	Eye Diseases
D010342	Patient Acceptance of Health Care
D000074822	Treatment Adherence and Compliance

Browse Leaves

Not provided

Browse Branches

Not provided